SS Innovations International, Inc.
SSII Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$2.25
KIRA · Stoqly’s AI analyst, in plain words
- SS Innovations International, Inc. had $42.5M of revenue in fiscal 2025, up 105.7% on the year before.
- Its operating margin was −19.3%, up 72.6 pts: of every 100 in sales, about −19 is left after running the business.
- SS Innovations International, Inc. lost $12.1M in fiscal 2025.
- Free cash flow was −$22.2M in fiscal 2025, −52.3% of revenue.
Market cap
$471M
P/E
—
Revenue
$42.5M
Net income
−$12.1M
Free cash flow
−$22.2M
Operating margin
−19.3%
SS Innovations International, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+105.7%
Yes. Sales grew 105.7% last year.
Does it make a profit?
−28.5%
No. It lost money last year.
Does profit turn into cash?
−52.3%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What SS Innovations International, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 10, 2026
- Legal name
- SS Innovations International, Inc.
- CIK
- 0001676163
SS Innovations International, Inc. · SSII
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | — | $1.4M | $5.9M | $20.6M | $42.5M |
| Revenue growth | — | — | 309.1% | 251.5% | 105.7% |
| Net interest income | — | $0.0M | $0.2M | $0.3M | $0.5M |
| Gross margin | — | 4.2% | 12.3% | 40.9% | 46.0% |
| Operating margin | — | −206.0% | −345.1% | −91.9% | −19.3% |
| Net income | −$1.5M | −$3.2M | −$20.9M | −$19.2M | −$12.1M |
| Net margin | — | −223.8% | −355.4% | −92.7% | −28.5% |
| Diluted EPS | −$0.05 | −$0.03 | −$0.14 | −$0.11 | −$0.06 |
| Cash | |||||
| Cash from operations | −$0.4M | −$6.0M | −$15.4M | −$9.5M | −$18.5M |
| Capital expenditure | — | $0.2M | $0.5M | $0.7M | $3.7M |
| Free cash flow | — | −$6.2M | −$15.8M | −$10.2M | −$22.2M |
| FCF margin | — | −432.8% | −269.2% | −49.2% | −52.3% |
| Share buybacks | $0.0M | — | — | — | — |
| Share count change | 21.9% | 350.0% | 18.7% | 19.2% | 9.7% |
| Debt and strength | |||||
| Cash and short-term investments | $0.4M | $0.2M | $2.0M | $0.5M | $3.2M |
| Debt incl. finance leases | — | $0.6M | $0.5M | — | — |
| Deposits | — | — | $5.0M | — | — |
| Shareholders' equity | $0.6M | −$2.7M | $19.7M | $13.5M | $38.2M |
| Current ratio | 1.4x | 0.5x | 2.5x | 1.3x | 1.9x |
| Interest coverage | — | −18.3x | −38.7x | −19.5x | −7.4x |
| Returns and quality | |||||
| Return on capital | — | — | −88.0% | — | — |
| Return on equity | — | — | −245.1% | −115.5% | −46.9% |
| Return on tangible equity | −253.5% | — | −106.2% | −142.3% | −31.7% |
| Piotroski F-score | — | — | 4 | 4 | 4 |
| Altman Z'' | — | −8.3 | −2.4 | −4.9 | −0.1 |
Insiders bought, 12 months
$5.2M
3 insiders
Insiders sold, 12 months
$0.1M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
SS Innovations International, Inc. · SSII
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.25 a share, the company is worth $471M.
Source: SEC EDGAR XBRL filings (CIK 0001676163). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.